| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Gabriela Neculae, Lucian Predescu, Oana Popa, Elena Rusu, Ruxandra Jurcu. Complex management of Fabry cardiomyopathy: a case report on the use of alcohol septal ablation and chaperone therapy. European heart journal. Case reports. vol 8. issue 7. 2024-07-18. PMID:39021360. |
cardiac involvement in fabry disease (fd) usually manifests as a concentric left ventricular hypertrophy with rare cases developing left ventricular outflow tract obstruction (lvoto), symptoms varying from fatigue and exercise associated dyspnoea to angina or arrhythmias. |
2024-07-18 |
2024-07-20 |
Not clear |
| Sophia Po-Yee Leung, Scott Dougherty, Xiao-Yu Zhang, Kevin K H Kam, Wai-Kin Chi, Joseph Y S Chan, Erik Fung, Jeffrey K T Wong, Paul C L Choi, David K H Chan, Bun Sheng, Alex Pui-Wai Le. The Asian Fabry Cardiomyopathy High-Risk Screening Study 2 (ASIAN-FAME-2): Prevalence of Fabry Disease in Patients with Left Ventricular Hypertrophy. Journal of clinical medicine. vol 13. issue 13. 2024-07-13. PMID:38999464. |
the asian fabry cardiomyopathy high-risk screening study 2 (asian-fame-2): prevalence of fabry disease in patients with left ventricular hypertrophy. |
2024-07-13 |
2024-07-15 |
Not clear |
| Gustavo Ferrari, Isaac Kisinovsky, Ricardo Reisin, Paula Rozenfeld, Pablo Neumann, Verónica Finn, Cintia Marchesoni, Pedro Quiet. Agalsidase alfa long-term effect on left ventricular hypertrophy in Fabry disease. Medicina. vol 84. issue 3. 2024-06-22. PMID:38907966. |
agalsidase alfa long-term effect on left ventricular hypertrophy in fabry disease. |
2024-06-22 |
2024-06-25 |
Not clear |
| Bernard P Paelinck, Antoine Bondue, Tomas Robyns, François Eysken. Left ventricular hypertrophy: do not forget Fabry disease. Diagnostic work-up and differential diagnosis. Acta cardiologica. 2024-06-13. PMID:38869089. |
left ventricular hypertrophy: do not forget fabry disease. |
2024-06-13 |
2024-06-15 |
Not clear |
| Niccolo Maurizi, Albina Nowak, Christiane Gruner, Mehdi Namdar, Christian Schmied, Alessandra Pia Porretta, Guillaume Barbey, Veronique Monzambani, Pierre Monney, Frédéric Barbe. Fabry disease: development and progression of left ventricular hypertrophy despite long-term enzyme replacement therapy. Heart (British Cardiac Society). 2024-05-15. PMID:38749654. |
fabry disease: development and progression of left ventricular hypertrophy despite long-term enzyme replacement therapy. |
2024-05-15 |
2024-05-27 |
Not clear |
| Wei-Wen Chen, Ling Kuo, Yi-Xun Lin, Wen-Chung Yu, Chien-Chao Tseng, Yenn-Jiang Lin, Ching-Chun Huang, Shih-Lin Chang, Jacky Chung-Hao Wu, Chun-Ku Chen, Ching-Yao Weng, Siwa Chan, Wei-Wen Lin, Yu-Cheng Hsieh, Ming-Chih Lin, Yun-Ching Fu, Tsung Chen, Shih-Ann Chen, Henry Horng-Shing L. A Deep Learning Approach to Classify Fabry Cardiomyopathy from Hypertrophic Cardiomyopathy Using Cine Imaging on Cardiac Magnetic Resonance. International journal of biomedical imaging. vol 2024. 2024-05-06. PMID:38706878. |
a challenge in accurately identifying and classifying left ventricular hypertrophy (lvh) is distinguishing it from hypertrophic cardiomyopathy (hcm) and fabry disease. |
2024-05-06 |
2024-05-08 |
Not clear |
| Wei-Wen Chen, Ling Kuo, Yi-Xun Lin, Wen-Chung Yu, Chien-Chao Tseng, Yenn-Jiang Lin, Ching-Chun Huang, Shih-Lin Chang, Jacky Chung-Hao Wu, Chun-Ku Chen, Ching-Yao Weng, Siwa Chan, Wei-Wen Lin, Yu-Cheng Hsieh, Ming-Chih Lin, Yun-Ching Fu, Tsung Chen, Shih-Ann Chen, Henry Horng-Shing L. A Deep Learning Approach to Classify Fabry Cardiomyopathy from Hypertrophic Cardiomyopathy Using Cine Imaging on Cardiac Magnetic Resonance. International journal of biomedical imaging. vol 2024. 2024-05-06. PMID:38706878. |
our proposed system named the mri short-axis view left ventricular hypertrophy classifier (mslvhc) is a high-accuracy standardized imaging classification model developed using ai and trained on mri short-axis (sax) view cine images to distinguish between hcm and fabry disease. |
2024-05-06 |
2024-05-08 |
Not clear |
| Hao-Chih Chang, Ling Kuo, Shih-Hsien Sung, Dau-Ming Niu, Wen-Chung Y. Prognostic implications of left ventricular hypertrophy and mechanical function in Fabry disease: A longitudinal cohort study. Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography. 2024-05-04. PMID:38704103. |
prognostic implications of left ventricular hypertrophy and mechanical function in fabry disease: a longitudinal cohort study. |
2024-05-04 |
2024-05-07 |
Not clear |
| Hao-Chih Chang, Ling Kuo, Shih-Hsien Sung, Dau-Ming Niu, Wen-Chung Y. Prognostic implications of left ventricular hypertrophy and mechanical function in Fabry disease: A longitudinal cohort study. Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography. 2024-05-04. PMID:38704103. |
the prognostic value of different grades of left ventricular hypertrophy (lvh) and left ventricular (lv) mechanical function in fabry disease is unclear. |
2024-05-04 |
2024-05-07 |
Not clear |
| Emanuele Monda, Athanasios Bakalakos, Robin Lachmann, Petros Syrris, Giuseppe Limongelli, Elaine Murphy, Derralynn Hughes, Perry Mark Elliot. Incidence and risk factors for development of left ventricular hypertrophy in Fabry disease. Heart (British Cardiac Society). 2024-04-30. PMID:38688703. |
incidence and risk factors for development of left ventricular hypertrophy in fabry disease. |
2024-04-30 |
2024-05-03 |
Not clear |
| Emanuele Monda, Athanasios Bakalakos, Robin Lachmann, Petros Syrris, Giuseppe Limongelli, Elaine Murphy, Derralynn Hughes, Perry Mark Elliot. Incidence and risk factors for development of left ventricular hypertrophy in Fabry disease. Heart (British Cardiac Society). 2024-04-30. PMID:38688703. |
left ventricular hypertrophy (lvh) is the principal cardiac manifestation of fabry disease (fd). |
2024-04-30 |
2024-05-03 |
Not clear |
| Maria Chiara Meucci, Rosa Lillo, Federica Mango, Mario Marsilia, Giulia Iannaccone, Filippo Tusa, Marco Luigetti, Elena Biagini, Massimo Massetti, Gaetano Antonio Lanza, Antonella Lombardo, Francesca Grazian. Left atrial structural and functional remodelling in Fabry disease and cardiac amyloidosis: A comparative analysis. International journal of cardiology. 2024-02-21. PMID:38382852. |
fabry disease (fd) and transthyretin cardiac amyloidosis (ttr ca) are cardiomyopathies with hypertrophic phenotype that share several features, including left atrial (la) enlargement and dysfunction, but direct comparative data are lacking. |
2024-02-21 |
2024-02-24 |
Not clear |
| Onur Akhan, Mehmet Kış, Tuncay Güzel, Mehdi Zogh. Differences Between Two Distinct Hypertrophic Cardiac Conditions: Fabry Disease versus Hypertrophic Cardiomyopathy. Arquivos brasileiros de cardiologia. vol 121. issue 1. 2024-02-07. PMID:38324858. |
differences between two distinct hypertrophic cardiac conditions: fabry disease versus hypertrophic cardiomyopathy. |
2024-02-07 |
2024-02-10 |
Not clear |
| Onur Akhan, Mehmet Kış, Tuncay Güzel, Mehdi Zogh. Differences Between Two Distinct Hypertrophic Cardiac Conditions: Fabry Disease versus Hypertrophic Cardiomyopathy. Arquivos brasileiros de cardiologia. vol 121. issue 1. 2024-02-07. PMID:38324858. |
hypertrophic cardiomyopathy (hcm) and fabry disease (fd) are genetically inherited diseases with left ventricular hypertrophy (lvh) phenotype characteristics that cause adverse cardiac outcomes. |
2024-02-07 |
2024-02-10 |
Not clear |
| Fu-Pang Chang, Ting-Rong Hsu, Sheng-Che Hung, Shih-Hsien Sung, Wen-Chung Yu, Dau-Ming Niu, Behzad Najafia. Cardiomyocyte Globotriaosylceramide Accumulation in Adult Male Patients with Fabry Disease and IVS4 + 919G>A GLA Mutation is Progressive with Age and Correlates with Left Ventricular Hypertrophy and Reduced Left Ventricular Ejection Fraction. medRxiv : the preprint server for health sciences. 2024-01-03. PMID:38168318. |
cardiomyocyte globotriaosylceramide accumulation in adult male patients with fabry disease and ivs4 + 919g>a gla mutation is progressive with age and correlates with left ventricular hypertrophy and reduced left ventricular ejection fraction. |
2024-01-03 |
2024-01-06 |
Not clear |
| Fu-Pang Chang, Ting-Rong Hsu, Sheng-Che Hung, Shih-Hsien Sung, Wen-Chung Yu, Dau-Ming Niu, Behzad Najafia. Cardiomyocyte Globotriaosylceramide Accumulation in Adult Male Patients with Fabry Disease and IVS4 + 919G>A GLA Mutation is Progressive with Age and Correlates with Left Ventricular Hypertrophy and Reduced Left Ventricular Ejection Fraction. medRxiv : the preprint server for health sciences. 2024-01-03. PMID:38168318. |
while cardiovascular complications are the most common cause of mortality in fabry disease, the relationship between globotriaosylceramide (gl-3) accumulation, the hallmark of fabry cardiomyopathy, and cardiac hypertrophy has not been fully elucidated. |
2024-01-03 |
2024-01-06 |
Not clear |
| Isabel Mattig, Tilman Steudel, Gina Barzen, David Frumkin, Sebastian Spethmann, Elena Romero Dorta, Karl Stangl, Bettina Heidecker, Ulf Landmesser, Fabian Knebel, Sima Canaan-Kühl, Katrin Hahn, Anna Bran. Diagnostic value of papillary muscle hypertrophy and mitral valve thickness to discriminate cardiac amyloidosis and Fabry disease. International journal of cardiology. 2023-12-04. PMID:38048880. |
diagnostic value of papillary muscle hypertrophy and mitral valve thickness to discriminate cardiac amyloidosis and fabry disease. |
2023-12-04 |
2023-12-10 |
Not clear |
| Kamil Stankowski, Stefano Figliozzi, Vincenzo Battaglia, Federica Catapano, Marco Francone, Lorenzo Mont. Fabry Disease: More than a Phenocopy of Hypertrophic Cardiomyopathy. Journal of clinical medicine. vol 12. issue 22. 2023-11-25. PMID:38002674. |
fabry disease: more than a phenocopy of hypertrophic cardiomyopathy. |
2023-11-25 |
2023-11-28 |
Not clear |
| Maomao Zhao, Xiaowei Niu, Lu Bai, Yinchang Zhang, Ting Wang, Yongling Wa, Junchu Wei, Kang Dong, Xin Zhang, Ming Ba. Unexplained Left Ventricular Hypertrophy Diagnosed as a Cardiac Variant of Late-Onset Fabry Disease: A Case Report. Journal of cardiovascular development and disease. vol 10. issue 9. 2023-09-27. PMID:37754818. |
unexplained left ventricular hypertrophy diagnosed as a cardiac variant of late-onset fabry disease: a case report. |
2023-09-27 |
2023-10-07 |
Not clear |
| Andrea Frustaci, Valentino Borghetti, Samuele Pentiricci, Romina Verardo, Rossella Scialla, Matteo Antonio Russ. Hypertrophic obstructive cardiomyopathy caused by Fabry disease: implications for surgical myectomy. ESC heart failure. 2023-09-16. PMID:37715354. |
hypertrophic obstructive cardiomyopathy caused by fabry disease: implications for surgical myectomy. |
2023-09-16 |
2023-10-07 |
Not clear |